Found 13 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C and Author is Luiz E Bermudez  [Clear All Filters]
2019
S. S. Chiplunkar, Silva, C. A., Bermudez, L. E., and Danelishvili, L., “Characterization of membrane vesicles released by Mycobacterium avium in response to environment mimicking the macrophage phagosome.”, Future Microbiol, vol. 14, pp. 293-313, 2019.
2005
M. Petrofsky and Bermudez, L. E., “CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route.”, Infection and immunity, vol. 73, no. 5, pp. 2621-7, 2005.
R. Roy MacGregor, Hafner, R., Wu, J. W., Murphy, R. L., Perlman, D. C., Bermudez, L. E., Inderlied, C. B., Picker, L. J., Wallis, R. S., Andersen, J. W., Mahon, L. F., Koletar, S. L., and Peterson, D. M., “Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.”, AIDS research and human retroviruses, vol. 21, no. 8, pp. 689-95, 2005.
2003
G. Carter, Wu, M., Drummond, D. C., and Bermudez, L. E., “Characterization of biofilm formation by clinical isolates of Mycobacterium avium.”, Journal of medical microbiology, vol. 52, no. Pt 9, pp. 747-52, 2003.
2001
L. E. Bermudez and Sangari, F. J., “Cellular and molecular mechanisms of internalization of mycobacteria by host cells.”, Microbes and infection / Institut Pasteur, vol. 3, no. 1, pp. 37-42, 2001.
A. Limia, Sangari, F. J., Wagner, D., and Bermudez, L. E., “Characterization and expression of secA in Mycobacterium avium.”, FEMS microbiology letters, vol. 197, no. 2, pp. 151-7, 2001.
2000
F. J. Sangari, Bächli, M., Bermudez, L. E., and Bodmer, T., “Characterization of IS666, a newly described insertion element of Mycobacterium avium.”, Microbial & comparative genomics, vol. 5, no. 4, pp. 181-8, 2000.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”, Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
1998
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., “Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”, The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
1996
T. Tojimbara, Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., and Esquivel, C. O., “Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro.”, Transplantation proceedings, vol. 28, no. 3, pp. 1381-2, 1996.
1995
L. E. Bermudez, Shelton, K., and Young, L. S., “Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.”, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
1994
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., “Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”, Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
1990
C. M. Black, Bermudez, L. E., Young, L. S., and Remington, J. S., “Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens.”, The Journal of experimental medicine, vol. 172, no. 3, pp. 977-80, 1990.